Gellhaus K[Author] - Search Results

Year	Number of Results
2006	1
2010	1
2011	1
2012	2
2013	2
2014	2
2016	1
2021	0

1

Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML.

Lichtenegger FS, Lorenz R, Gellhaus K, Hiddemann W, Beck B, Subklewe M. Lichtenegger FS, et al. Among authors: gellhaus k. Leuk Res. 2014 Aug;38(8):964-9. doi: 10.1016/j.leukres.2014.05.014. Epub 2014 Jun 2. Leuk Res. 2014. PMID: 24957413

2

The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics.

Barth SD, Kaaks R, Johnson T, Katzke V, Gellhaus K, Schulze JJ, Olek S, Kühn T. Barth SD, et al. Among authors: gellhaus k. EBioMedicine. 2016 Sep;11:151-156. doi: 10.1016/j.ebiom.2016.07.035. Epub 2016 Jul 30. EBioMedicine. 2016. PMID: 27499494 Free PMC article.

3

The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting.

Rahman SH, Bobis-Wozowicz S, Chatterjee D, Gellhaus K, Pars K, Heilbronn R, Jacobs R, Cathomen T. Rahman SH, et al. Among authors: gellhaus k. Hum Gene Ther. 2013 Jan;24(1):67-77. doi: 10.1089/hum.2012.168. Epub 2012 Dec 10. Hum Gene Ther. 2013. PMID: 23072634 Free PMC article.

4

Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.

Händel EM, Gellhaus K, Khan K, Bednarski C, Cornu TI, Müller-Lerch F, Kotin RM, Heilbronn R, Cathomen T. Händel EM, et al. Among authors: gellhaus k. Hum Gene Ther. 2012 Mar;23(3):321-9. doi: 10.1089/hum.2011.140. Epub 2011 Dec 14. Hum Gene Ther. 2012. PMID: 21980922 Free PMC article.

5

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns.

Türbachova I, Schwachula T, Vasconcelos I, Mustea A, Baldinger T, Jones KA, Bujard H, Olek A, Olek K, Gellhaus K, Braicu I, Könsgen D, Fryer C, Ravot E, Hellwag A, Westerfeld N, Gruss OJ, Meissner M, Hasan MT, Weber M, Hoffmüller U, Zimmermann S, Loddenkemper C, Mahner S, Babel N, Berns E, Adams R, Zeilinger R, Baron U, Vergote I, Maughan T, Marme F, Dickhaus T, Sehouli J, Olek S. Türbachova I, et al. Among authors: gellhaus k. Epigenetics. 2013 Nov;8(11):1226-35. doi: 10.4161/epi.26334. Epub 2013 Sep 26. Epigenetics. 2013. PMID: 24071829

6

Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells.

Gellhaus K, Cornu TI, Heilbronn R, Cathomen T. Gellhaus K, et al. Hum Gene Ther. 2010 May;21(5):543-53. doi: 10.1089/hum.2009.167. Hum Gene Ther. 2010. PMID: 20021219

7

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P, Vergote I, Mahner S, Cacsire-Tong D, Concin N, Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI. Ruscito I, et al. Among authors: gellhaus k. Eur J Cancer. 2014 Aug;50(12):2090-8. doi: 10.1016/j.ejca.2014.05.001. Epub 2014 Jun 2. Eur J Cancer. 2014. PMID: 24889916

8

Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break.

Radecke F, Peter I, Radecke S, Gellhaus K, Schwarz K, Cathomen T. Radecke F, et al. Among authors: gellhaus k. Mol Ther. 2006 Dec;14(6):798-808. doi: 10.1016/j.ymthe.2006.06.008. Epub 2006 Aug 14. Mol Ther. 2006. PMID: 16904944 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results